Refine by
Patient Selection Articles & Analysis
15 articles found
Marrying this approach with the ability to deploy a biomarker-based strategy for selecting targeted patient cohorts can significantly derisk the clinical trial process ...
Clinical trials are the backbone of modern medicine, responsible for bringing innovative, safe, and efficient treatments to market after rigorous testing and evaluation. However, the conventional process of conducting these trials has often been long, expensive, and fraught with inefficiencies¹. The advent of predictive analytics is reshaping the landscape of clinical trials, ushering in a ...
Dr. Kate Sasser from Tempus led a discussion on the potential of antibody-drug conjugates (ADCs), their challenges in targeting tumor antigens, and the future of cancer treatment with Dr. Daniel Johnson, Dr. Funda Meric-Bernstam, and Dr. Kellogg Parsons. The oncology field is rapidly advancing with the development of antibody-drug conjugates (ADCs), offering new hope for ...
ByTempus
A user had to be able to easily navigate between samples, the source of the samples (patients) and the storage area. This would enable questions such as “show me all the samples for a given patient” or “show me where in the container a specific sample is” to be answered. ...
During the webinar, you’ll learn about: Treatment options and unmet needs of HFrEF patients The physiologic rationale of baroreflex activation Barostim therapy overview and clinical evidence overview Appropriate patient selection and real-world experience Important Safety Information CAUTION: Federal ...
ByCVRx
We also discuss challenges posed in clinical trial design for these novel device–based strategies including optimal patient selection and appropriate end points to establish efficacy. ...
Current guidelines recommend adjuvant treatment only for selected patients with stage II or higher disease. A prediction model that identifies patients at high risk of recurrence who may benefit from adjuvant treatment is greatly needed. ...
Materials and Methods We analyzed gene expression in frozen lung cancer tissue from 59 selected patients who had undergone surgical resection of NSCLC. These patients were divided into two groups: group R, patients who had a tumor recurrence within four years, n=37; group NR, patients who remained disease-free ...
As an orthotics and prosthetics practice, attracting and retaining patients can be challenging. While there are millions of limb loss patients around the world, they may all be searching for different solutions. Consequently, it’s important to showcase your professional talents as a clinician as well as offer custom solutions to your patients’ needs. But, not to worry. We’ve ...
In Figure 1, is possible to see the new design, in the top, is visible the status of platform, if it is connected or not, and also if exists one patient selected. Then the interface is divided in two main areas. Left area has the steps of the protocol, the timer and the buttons to start, pause, stop or save and export data. ...
Our frustration is shared by the doctor, who has had success with that procedure or drug on patients just like us. Medical device companies are in the middle of this. ...
ByRestech
Methods: Hip DXA images from a subset of randomly selected patients in the ACTIVE trial (n = 250/arm) were retrospectively analyzed using three-dimensional modeling methods (3D-SHAPER software) to evaluate changes from baseline at months 6 and 18. ...
After seven years and 5,300-patients tested, the results of the landmark TAILOR-PCI trial were announced in a virtual ACC session. This trial investigated whether a prospective approach using rapid on-site CYP2C19 testing could improve patient outcomes when selecting P2Y12 inhibitor therapy following PCI procedure. ...
Hopefully, by standardizing equipment, technique, and endpoints, LimFlow’s pDVA system will prove to be reproducible, safe, and successful in dealing with no-option CLTI patients. A 4-STEP FLOWCHART FOR SELECTING NO-OPTION CLTI PATIENTS FOR pDVA According to the Global Vascular Guidelines, all evidence-based revascularization in ...
We are seeking qualified surgeons to collect outcome data for patients whose fractures have been treated with the T-Pin System. Subjetive and objective assessment of factors such as patient selection factors, intraoperative observations and clinical pearls, and postoperative assessment will be ...